Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Biomarin Pharmaceutical Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Apr 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Biomarin Pharmaceutical Inc (BMRN-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

27 May 2016 Thomson Reuters Stock Report 12 $25.00

Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of BIOMARIN PHARMACEUTICAL INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.

20 May 2016 Jefferson Research 11 $20.00

BMRN.OQ - Event Transcript of Biomarin Pharmaceutical Inc conference call, May 11, 2016 / 1:00PM ET

Edited Event Transcript of BMRN.OQ conference call, May 11, 2016 / 1:00PM ET Las Vegas, May 12, 2016 (Thomson StreetEve...

11 May 2016 Thomson Reuters StreetEvents 9 $75.00

Wright Investors Service Comprehensive Report for Biomarin Pharmaceutical Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

11 May 2016 Wright Reports 56 $75.00

BioMarin Pharmaceutical Inc. (BMRN) - Financial and Strategic SWOT Analysis Review

BioMarin Pharmaceutical Inc. (BMRN) - Financial and Strategic SWOT Analysis Review Summary BioMarin Pharmaceutical Inc. (BioM...

10 May 2016 GlobalData 91 $300.00

BioMarin Pharmaceutical Inc. (NASDAQ- BMRN)

BioMarin, founded in 1997, develops and commercializes innovative biopharmaceuticals for serious diseases and medical condit...

09 May 2016 Acquisdata 13 $15.00

Will BioMarin Pharmaceutical Inc. Deliver Long-Term Returns?

09 May 2016 Sadif Analytics Prime 12 $25.00

Trading Report for (BMRN). A detailed report, including free correlated market analysis, and updates.

Detailed Trading Report for BMRN. Entry levels, target prices, and risk controls are integral. In addition, free market anal...

02 May 2016 Stock Traders Daily 6 $20.00

Thomson Reuters Stock Report - Biomarin Pharmaceutical Inc (BMRN-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

01 May 2016 Thomson Reuters Stock Report 12 $25.00